Table 1 Mass/NME in relation to molecular subtype and their dynamic curve assessment:
From: Evaluation of molecular subtypes of breast cancer using MRI BI-RADS Lexicon
Luminal (N = 130) | Non-luminal (N = 40) | P | |
|---|---|---|---|
Mass/non-mass lesions | |||
Mass lesions | 108 (83.1%) | 22 (55.0%) | 0.002* |
Non-mass lesions | 22 (16.9%) | 18 (45.0%) | |
Dynamic enhancing curve | |||
Plateau (type II curve) | 52 (40%) | 4 (10%) | 0.0004* |
Washout (type III curve) | 78 (60%) | 36 (90%) | |